Shree Ganesh (SGRL) | Financial Analysis & Statements
Shree Ganesh Remedies Ltd. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Sep 2025Income Metrics
Revenue
303.2M
Gross Profit
177.2M
58.46%
Operating Income
70.3M
23.19%
Net Income
49.6M
16.35%
EPS (Diluted)
₹3.86
Balance Sheet Metrics
Total Assets
2.0B
Total Liabilities
505.9M
Shareholders Equity
1.5B
Debt to Equity
0.33
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Sep 30, 2025
Annual Income Flow
2025
Shree Ganesh Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.1B | 1.3B | 902.2M | 712.9M | 490.8M |
| Cost of Goods Sold | 361.7M | 584.8M | 471.6M | 370.5M | 220.2M |
| Gross Profit | 703.3M | 674.2M | 430.6M | 342.4M | 270.6M |
| Gross Margin % | 66.0% | 53.6% | 47.7% | 48.0% | 55.1% |
| Operating Expenses | |||||
| Research & Development | 2.6M | 235.0K | - | - | - |
| Selling, General & Administrative | 28.6M | 22.9M | 18.7M | 9.0M | 8.0M |
| Other Operating Expenses | 175.3M | 128.1M | 88.2M | 81.3M | 50.6M |
| Total Operating Expenses | 206.5M | 151.2M | 106.9M | 90.3M | 58.7M |
| Operating Income | 301.9M | 357.0M | 203.1M | 151.0M | 112.6M |
| Operating Margin % | 28.3% | 28.4% | 22.5% | 21.2% | 22.9% |
| Non-Operating Items | |||||
| Interest Income | 188.0K | 646.0K | 1.3M | 1.5M | 1.6M |
| Interest Expense | 20.1M | 5.5M | 446.0K | 1.0M | 304.0K |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 312.7M | 381.6M | 225.8M | 180.1M | 129.5M |
| Income Tax | 82.0M | 100.5M | 55.6M | 46.1M | 32.0M |
| Effective Tax Rate % | 26.2% | 26.3% | 24.6% | 25.6% | 24.7% |
| Net Income | 230.7M | 281.1M | 170.2M | 134.0M | 97.5M |
| Net Margin % | 21.7% | 22.3% | 18.9% | 18.8% | 19.9% |
| Key Metrics | |||||
| EBITDA | 420.8M | 445.8M | 265.4M | 213.0M | 157.1M |
| EPS (Basic) | ₹17.96 | ₹22.34 | ₹14.01 | ₹11.08 | ₹9.68 |
| EPS (Diluted) | ₹17.96 | ₹22.34 | ₹14.01 | ₹11.08 | ₹9.68 |
| Basic Shares Outstanding | 12844836 | 12583000 | 12143896 | 12092667 | 10077452 |
| Diluted Shares Outstanding | 12844836 | 12583000 | 12143896 | 12092667 | 10077452 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Shree Ganesh Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 99.4M | 158.5M | 86.5M | 38.8M | 34.7M |
| Short-term Investments | 182.8M | 46.6M | 25.0M | - | 31.2M |
| Accounts Receivable | 222.7M | 203.3M | 279.2M | 183.8M | 133.3M |
| Inventory | 220.2M | 249.9M | 181.8M | 136.4M | 127.1M |
| Other Current Assets | 40.9M | 1.0K | - | -1.0K | 1.0K |
| Total Current Assets | 775.8M | 702.0M | 642.9M | 449.1M | 379.9M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 31.6M | 19.6M | 13.1M | 11.8M | 22.4M |
| Goodwill | 4.7M | 3.6M | 7.4M | 8.5M | 11.7M |
| Intangible Assets | 4.7M | 3.6M | 3.6M | 931.0K | 445.0K |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | -3.0K | -1.0K | 3.0K | 500.0K | 963.1K |
| Total Non-Current Assets | 1.1B | 1.0B | 795.4M | 321.1M | 226.1M |
| Total Assets | 1.9B | 1.7B | 1.4B | 770.2M | 606.0M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 59.7M | 81.9M | 145.3M | 94.7M | 62.1M |
| Short-term Debt | 87.8M | 72.1M | 25.8M | - | 2.1M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 1.7M | -1.0K | - | - | 415.0K |
| Total Current Liabilities | 161.8M | 186.8M | 237.4M | 150.4M | 101.9M |
| Non-Current Liabilities | |||||
| Long-term Debt | 296.1M | 292.4M | 309.3M | - | - |
| Deferred Tax Liabilities | 5.3M | 5.8M | - | 2.0M | 2.4M |
| Other Non-Current Liabilities | 10.0K | - | - | - | -1.0K |
| Total Non-Current Liabilities | 306.0M | 301.6M | 311.6M | 4.0M | 4.1M |
| Total Liabilities | 467.9M | 488.4M | 549.0M | 154.4M | 105.9M |
| Equity | |||||
| Common Stock | 128.4M | 128.4M | 125.1M | 120.1M | 100.1M |
| Retained Earnings | 1.1B | 867.2M | 610.6M | 447.2M | 331.5M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.5B | 1.2B | 889.4M | 615.7M | 500.0M |
| Key Metrics | |||||
| Total Debt | 383.8M | 364.5M | 335.1M | 0 | 2.1M |
| Working Capital | 613.9M | 515.2M | 405.5M | 298.7M | 278.0M |
Balance Sheet Composition
Shree Ganesh Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 312.7M | 381.6M | 225.8M | 180.1M | 129.5M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | 3.6M | 16.9M | -93.2M | -87.0M | -24.1M |
| Operating Cash Flow | 337.1M | 403.9M | 135.2M | 36.8M | -831.6K |
| Investing Activities | |||||
| Capital Expenditures | -231.8M | -311.3M | -515.5M | -153.3M | -90.0K |
| Acquisitions | 0 | - | - | - | -172.0K |
| Investment Purchases | -128.3M | -44.1M | 0 | -174.0K | -10.0M |
| Investment Sales | 3.3M | 24.8M | 0 | 34.3M | 840.0K |
| Investing Cash Flow | -356.8M | -330.7M | -535.7M | -119.1M | -8.6M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | -6.3M | -6.0M | -16.1M | - |
| Debt Issuance | - | - | - | - | - |
| Debt Repayment | - | - | - | -788.0K | -5.0M |
| Financing Cash Flow | 1.0K | 67.4M | 104.0M | -10.9M | -6.6M |
| Free Cash Flow | 74.7M | -6.9M | -345.7M | -19.1M | 33.0M |
| Net Change in Cash | -19.6M | 140.6M | -296.6M | -93.2M | -16.0M |
Cash Flow Trend
Shree Ganesh Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
37.03
Price to Book
4.36
Price to Sales
6.66
PEG Ratio
-0.86
Profitability Ratios
Profit Margin
17.99%
Operating Margin
19.25%
Return on Equity
15.89%
Return on Assets
12.02%
Financial Health
Current Ratio
4.00
Debt to Equity
24.45
Beta
0.19
Per Share Data
EPS (TTM)
₹14.09
Book Value per Share
₹119.59
Revenue per Share
₹78.28
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| SGRL | 6.7B | 37.03 | 4.36 | 15.89% | 17.99% | 24.45 |
| Sun Pharmaceutical | 3.9T | 36.73 | 5.15 | 15.08% | 19.21% | 6.68 |
| Divi's Laboratories | 1.7T | 67.11 | 10.82 | 14.64% | 24.04% | 0.58 |
| Sun Pharma Advanced | 46.7B | -13.65 | -13.55 | 157.88% | -53.22% | -1.21 |
| Innova Captab | 41.4B | 31.20 | 4.05 | 13.37% | 8.85% | 32.95 |
| Gujarat Themis | 35.4B | 73.73 | 13.36 | 19.64% | 29.99% | 27.04 |
Financial data is updated regularly. All figures are in the company's reporting currency.





